NEW YORK ( TheStreet) -- Questcor Pharmaceuticals (Nasdaq: QCOR) hit a new 52-week high Wednesday as it is currently trading at $44.77, above its previous 52-week high of $44.51 with 249,528 shares traded as of 10:10 a.m. ET. Average volume has been 1.2 million shares over the past 30 days. Questcor has a market cap of $2.59 billion and is part of the health care sector and drugs industry. Shares are up 190.8% year to date as of the close of trading on Tuesday. Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription drugs for the treatment of auto-immune diseases. The company's primary product is H.P. The company has a P/E ratio of 52.9, above the average drugs industry P/E ratio of 50.4 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter